Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 14;8(1):65-79.
doi: 10.1159/000546263. eCollection 2025 Jan-Dec.

Pilot-Scale Preparation of Broad-Spectrum CBD: Extraction Optimization and Purification using Centrifugal Partition Chromatography

Affiliations

Pilot-Scale Preparation of Broad-Spectrum CBD: Extraction Optimization and Purification using Centrifugal Partition Chromatography

Vorawut Wongumpornpinit et al. Med Cannabis Cannabinoids. .

Abstract

Introduction: Cannabinoids, a class of compounds found in Cannabis sativa L., possess a wide range of pharmacological properties. While Δ9-tetrahydrocannabinol (Δ9-THC) is strictly regulated owing to its psychoactive effects, cannabidiol (CBD), a nonpsychoactive compound, is permitted in certain countries. This study aimed to optimize the preparation of ethanolic cannabis extracts using response surface methodology (RSM) and develop an effective system for removing Δ9-THC through centrifugal partition chromatography (CPC) to produce broad-spectrum CBD (hemp extract containing CBD and other compounds with minimal or no Δ9-THC).

Methods: Three variables and six responses were assessed to optimize extraction conditions. Predictions were made using Design-Expert® software, and the experimental conditions were identified using the Box-Behnken design (BBD). The extracts were analyzed using high-performance liquid chromatography and a chromameter. Optimal conditions were used for pilot-scale extraction, and the CPC process was optimized by determining the partition coefficient of the target cannabinoids in various solvent systems and maximum sample load.

Results: The optimal extraction conditions were -31°C for 33 min and a sample-to-solvent ratio of 1:8% w/v, with a desirability value of 0.576. Temperature was the most influential factor. Although the total yield decreased, this condition provided the highest concentration of light-colored cannabinoids and was successfully scaled up for the three other cannabis samples. The optimal CPC solvent system, consisting of hexane/0.1% FA in ACN/20 mm ammonium formate at a ratio of 10/6.5/3.5 v/v/v, demonstrated a yield recovery of 89.3 ± 0.21% w/w with a maximum load of 5 g of sample per run. The resulting broad-spectrum CBD extract had a high CBD content (73.3 ± 0.37% w/w) and minimal Δ9-THC content (0.2 ± 0.00% w/w).

Conclusion: BBD-RSM optimization of ethanolic cannabis extraction provided the highest cannabinoid concentration with a short extraction time and desirable appearance. The CPC process successfully separated Δ9-THC, yielding a high-purity broad-spectrum CBD extract.

Keywords: Broad-spectrum cannabidiol; Cannabinoids; Centrifugal partition chromatography; Extraction optimization.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Figures

Fig. 1.
Fig. 1.
3D surface plots illustrate the interactive effects of temperature and extraction time on the % yield (a), % CBD (b), % CBDA (c), % Δ9-THC (d), % THCA (e), and (f) lightness of the cannabis extract. The sample-to-solvent ratio was fixed at 1:7 (w/v) in all experiments.
Fig. 2.
Fig. 2.
The plots of cannabinoid content in the fractions obtained from CPC separation with 3 g (a), 4 g (b), 5 g (c), 6 g (d), and 7 g of sample loaded (e). The CPC runs for 100 min in ascending mode and 50 min in descending mode, as described in the Methods section.

Similar articles

References

    1. Andre CM, Hausman JF, Guerriero G. Cannabis sativa: the plant of the thousand and one molecules. Front Plant Sci. 2016;7:19. - PMC - PubMed
    1. Wishart DS, Hiebert-Giesbrecht M, Inchehborouni G, Cao X, Guo AC, LeVatte MA, et al. Chemical composition of commercial cannabis. J Agric Food Chem. 2024;72(25):14099–113. - PMC - PubMed
    1. Stasiłowicz A, Tomala A, Podolak I, Cielecka-Piontek J. Cannabis sativa L. as a natural drug meeting the criteria of a multitarget approach to treatment. Int J Mol Sci. 2021;22(2):778. - PMC - PubMed
    1. Binkowska AA, Jakubowska N, Redeł A, Laskowska S, Szlufik S, Brzezicka A. Cannabidiol usage, efficacy, and side effects: analyzing the impact of health conditions, medications, and cannabis use in a cross-sectional online pilot study. Front Psychiatry. 2024;15:1356009. - PMC - PubMed
    1. Kirkland AE, Fadus MC, Gruber SA, Gray KM, Wilens TE, Squeglia LM. A scoping review of the use of cannabidiol in psychiatric disorders. Psychiatry Res. 2022;308:114347. - PMC - PubMed

LinkOut - more resources